Skye Bioscience, Inc. (SKYE)
0.7144
+0.02
(+2.35%)
USD |
NASDAQ |
Apr 06, 16:00
0.7085
-0.01
(-0.83%)
After-Hours: 20:00
Skye Bioscience SG&A Expense (TTM) : 15.80M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Halozyme Therapeutics, Inc. | 207.09M |
| Merck & Co., Inc. | 10.73B |
| SIGA Technologies, Inc. | 21.21M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |